MIRA INFORM REPORT

 

 

Report Date :

05.01.2013

 

IDENTIFICATION DETAILS

 

Name :

ENCUBE ETHICALS PRIVATE LIMITED

 

 

Registered Office :

Unit No. 24, Steelmada Industrial Estate, Marol  Village, Andheri (East), Mumbai – 400 059, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

07.09.1995

 

 

Com. Reg. No.:

11-092485

 

 

Capital Investment / Paid-up Capital :

Rs.15.000 Millions

 

 

CIN No.:

[Company Identification No.]

U24230MH1995PTC092485

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUME02391E

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturing of Dermatological, Pharmaceutical and Therapeutic Preparations, Patent Medicines, Drugs, etc.

 

 

No. of Employees :

400 (Approximately)

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (45)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 1600000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track record. The latest financials are not made available with the government department.

 

As per previous year’s, the company performance seem to be high. Financial company appears to be strong. Liquidity position is good. Trade relations are reported as fair. Business is active. Payments are reported to be usually correct and as per commitment.

 

The company can be considered for normal business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

India is developing into an open-market economy, yet traces of its past autarkic policies remain. Economic liberalization, including industrial deregulation, privatization of state-owned enterprises, and reduced controls on foreign trade and investment, began in the early 1990s and has served to accelerate the country's growth, which has averaged more than 7% per year since 1997. India's diverse economy encompasses traditional village farming, modern agriculture, handicrafts, a wide range of modern industries, and a multitude of services. Slightly more than half of the work force is in agriculture, but services are the major source of economic growth, accounting for more than half of India's output, with only one-third of its labor force. India has capitalized on its large educated English-speaking population to become a major exporter of information technology services and software workers. In 2010, the Indian economy rebounded robustly from the global financial crisis - in large part because of strong domestic demand - and growth exceeded 8% year-on-year in real terms. However, India's economic growth in 2011 slowed because of persistently high inflation and interest rates and little progress on economic reforms. High international crude prices have exacerbated the government's fuel subsidy expenditures contributing to a higher fiscal deficit, and a worsening current account deficit. Little economic reform took place in 2011 largely due to corruption scandals that have slowed legislative work. India's medium-term growth outlook is positive due to a young population and corresponding low dependency ratio, healthy savings and investment rates, and increasing integration into the global economy. India has many long-term challenges that it has not yet fully addressed, including widespread poverty, inadequate physical and social infrastructure, limited non-agricultural employment opportunities, scarce access to quality basic and higher education, and accommodating rural-to-urban migration.

Source : CIA

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

LOCATIONS

 

Registered Office :

Unit No. 24, Steelmada Industrial Estate, Marol  Village, Andheri (East), Mumbai – 400 059, Maharashtra, India

Tel. No.:

91-22-66783848 (3 Lines) / 28503838/ 28504335 / 28508612 / 29204335 / 29204336 / 29203838 / 29204336

Fax No.:

91-22-28504336 / 29204336

E-Mail :

encube@bom3.vsnl.net.in

encube.mumbai@encubeethicals.com 

mehul.shah@encubeethicals.com

kirit.v@encubeethicals.com

chirag.gandhi@encubeethicals.com

Website :

http://www.encubeethicals.com

Location :

Owned

 

 

Factory :

Plot No. C-1, Madkaim Industrial Estate, Madkaim, Post : Mardol, Ponda, Goa – 403 404, India

Tel. No.:

91-832-2392223 / 2392314

Fax No.:

91-832-2392225

E-Mail :

encube@sancharnet.in

prashant.j@encubeethicals.com

encube.goa@encubeethicals.com

 

 

DIRECTORS

 

As on: 21.09.2012

 

Name :

Mr. Mehul Madhusudan Shah

Designation :

Director

Address :                             

52/B/402, Ruby Apartment, 4th Floor, JVPD Scheme No.7, Mumbai – 400 049, Maharashtra, India 

Date of Birth/Age :

21.07.1966

Date of Appointment :

07.09.1995

DIN No.:

00312359 

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24230MH1995PTC092485

ENCUBE ETHICALS PRIVATE LIMITED

Director

07/09/1995

07/09/1995

-

Active

NO

2

U24239MH1981PTC024506

RELIEF PHARMACEUTICALS PRIVATE LIMITED

Director

31/10/1998

31/10/1998

-

Active

NO

3

U67120MH2000PTC124315

ENCUBE INVESTMENT AND TRADING PRIVATE LIMITED

Director

25/11/2005

25/11/2005

-

Active

NO

 

 

Name :

Mr. Madhusudan Nyalchandh Shah

Designation :

Director

Address :

52/B/402, Ruby Apartment, 4th Floor, JVPD Scheme No.7, Mumbai – 400 049, Maharashtra, India 

Date of Birth/Age :

30.11.1934

Date of Appointment :

07.09.1995

DIN No.:

00314267

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24239MH1981PTC024506

RELIEF PHARMACEUTICALS PRIVATE LIMITED

Director

30/05/1981

30/05/1981

-

Active

NO

2

U24230MH1995PTC092485

ENCUBE ETHICALS PRIVATE LIMITED

Director

07/09/1995

07/09/1995

-

Active

NO

3

U67120MH2000PTC124315

ENCUBE INVESTMENT AND TRADING PRIVATE LIMITED

Director

25/11/2005

25/11/2005

-

Active

NO

 

 

Name :

Mr. Nilesh Navin Maniar

Designation :

Director

Address :

1 Ashish 51 C, S V Road, Santacruz (West), Mumbai – 400 054, Maharashtra, India

Date of Birth/Age :

06.07.1960

Date of Appointment :

30.01.2002

DIN No.:

00330165

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U65990MH1990PTC058485

KENIL FINANCIAL AND CONSULTANCY SERVICES PRIVATE LIMITED

Director

10/10/1990

10/10/1990

01/01/2009

Active

NO

2

U24230MH1995PTC092485

ENCUBE ETHICALS PRIVATE LIMITED

Director

30/01/2002

30/01/2002

-

Active

NO

3

U67120MH2000PTC124315

ENCUBE INVESTMENT AND TRADING PRIVATE LIMITED

Director

15/09/2004

15/09/2004

-

Active

NO

4

U67190MH2007PTC171861

ANVIL WEALTH MANAGEMENT PRIVATE LIMITED

Director

21/06/2007

21/06/2007

-

Active

NO

5

U67120MH1997PTC109640

ANVIL SHARE AND STOCK BROKING PRIVATE LIMITED

Director

18/09/2008

11/02/2008

-

Active

NO

6

U45209MH2011PTC224359

UNIQUE SKYLINES PRIVATE LIMITED

Director

24/11/2011

24/11/2011

-

Active

NO

7

U74120MH2012PTC239115

ANVIL COMMODITIES PRIVATE LIMITED

Director

26/12/2012

26/12/2012

-

Active

NO

 

 

Name :

Mr. Himanshu Mahendra Gandhi

Designation :

Director

Address :

B-302 Gokul Gagan, Thakur Village, Kandivali (East), Mumbai – 400 101, Maharashtra, India

Date of Birth/Age :

23.01.1970

Date of Appointment :

30.01.2002

DIN No.:                  

00784178

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U67120MH1997PTC109640

ANVIL SHARE AND STOCK BROKING PRIVATE LIMITED

Director

01/09/1997

01/09/1997

-

Active

NO

2

U24230MH1995PTC092485

ENCUBE ETHICALS PRIVATE LIMITED

Director

30/01/2002

30/01/2002

-

Active

NO

3

U67120MH2000PTC124315

ENCUBE INVESTMENT AND TRADING PRIVATE LIMITED

Director

15/09/2004

15/09/2004

-

Active

NO

4

U74120MH2012PTC239115

ANVIL COMMODITIES PRIVATE LIMITED

Director

26/12/2012

26/12/2012

-

Active

NO

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on: 21.09.2012

 

Names of Shareholders

 

No. of Shares

Madhusudan Nyalchandh Shah

 

600000

Mehul Madhusudan Shah

 

600000

Madhusudan Nyalchandh Shah HUF

 

10

Mehul Madhusudan Shah HUF

 

10

Nilesh Navin Maniar

 

20

Himanshu Mahendra Gandhi

 

20

Chandra M Shah

 

225000

Niti M Shah

 

74890

Chandramani Maniar

 

20

Pinki H Gandhi

 

20

Rupa N Maniar

 

20

Bipin G Gandhi

 

20

 

 

 

Total

 

1500030

 

Equity Share Break up (Percentage of Total Equity)

 

As on: 21.09.2012

 

Category

 

Percentage

 

 

 

Directors or relatives of directors

 

100.00

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing of Dermatological, Pharmaceutical and Therapeutic Preparations, Patent Medicines, Drugs, etc.

 

 

Products :

·         Cracked Heel Cream

·         Dermocalm Lotion

·         Eulactol Heel Balm  

 

 

PRODUCTION STATUS (AS ON 31.03.2011)

 

Particulars

Unit

Installed Capacity

(Single Shift)

Actual Production

Non Sterile Ointments 

Tones

3960

3049.81

 

 

GENERAL INFORMATION

 

Customers :

·         Corporate

·         Galderma

·         Sanofi

·         Pigeon

·         Dr. Reddy’s

·         L’oreal India 

·         Spirig

·         Remedia

·         Mega

·         Johnson and Johnson

·         Amra

·         Jenburkt

·         Ranbaxy

·         GSK GlaxoSmithKline

·         Micro Labs

·         Smith and Nephew

·         Dr Scholl          

·         Bayer

·         Crawford Healthcare

·         Life Star

·         Curatio

 

 

No. of Employees :

400 (Approximately)

 

 

Bankers :

·         HDFC Bank Limited, HDFC Bank House, Senapati Bapat Marg, Lower Parel West, Mumbai – 400 013, Maharashtra, India

 

·         Janakalyan Saharaki Bank Limited, 140, Vivek Darshan, Sindhi Society, Opposite Bhakti Bhavan, Chembur, Mumbai – 400 071, Maharashtra, India

 

·         Small Industrial Development Bank of India, New Horizone, 1st Floor, St. Mary’s Colony, Dayanand Bandodkar Marg, Miramar, Panji – 403001, Goa, India

 

·         ICICI Bank Limited, Landmarkrace Cource Circle, Alkapuri, Baroda – 390 015, Gujarat, India

·         ICICI Bank Limited, 1st Floor, Sagar Avenue, Opposite Shopper Stop, Andheri (West), Mumbai – 400053, Maharashtra, India

 

 

Facilities :

(Rs. In Millions)

Secured Loans

As on

31.03.2011

As on

31.03.2010

Term Loan

 

 

Term Loan from SIDBI

(Secured against hypothecation of Land)

0.000

1.480

Overdraft

 

 

From Janakalyan Saharaki Bank Limited

(Secured against Fixed Deposit)

(0.013)

0.902

From ICICI Bank Limited

(Secured against Fixed Deposit)

0.000

(0.077)

BNP Paribas Limited

(Secured against property)

121.683

(0.041)

Cash Credit

 

 

HDFC Bank

(Secured against book debts and Stock)

8.494

10.252

Total

130.164

12.516

 

 

Unsecured Loans

As on

31.03.2011

As on

31.03.2010

Loans from Shareholders

109.774

270.067

Loans from others

0.100

0.100

 

 

 

Total

109.874

270.167

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Shaparia and Mehta

Chartered Accountants

Address :

1/74, Krishna Kunj, R. A. Kidwai Road, King’s Circle, Matunga (Central Railway), Mumbai – 400 019, Maharashtra, India

Tel. No.:

91-22-24098905/ 06 / 07 / 08

Fax No.:

91-22-24098905/ 06 / 07 / 08

E-Mail :

sm.ca@vsnl.com

PAN No.:

AABFS3225N

 

 

Other Related Parties : 

·         Relief Pharmaceuticals Private Limited

·         Ciens Laboratories

·         Encube Investments and Trading Private Limited

·         Pharma Laboratories and Distributors

 

 

CAPITAL STRUCTURE

 

As on: 31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

2500000

Equity Shares

Rs.10/- each

Rs.25.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1500030

Equity Shares

Rs.10/- each

Rs.15.000 Millions

 

 

 

 

 

Note

 

(Of the above 1000000 Equity Shares of Rs.10/- each were allotted as fully paid bonus share by capitalization of General Reserve)

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

15.000

15.000

15.000

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

407.878

252.086

186.996

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

422.878

267.086

201.996

LOAN FUNDS

 

 

 

1] Secured Loans

130.164

12.516

32.030

2] Unsecured Loans

109.874

270.167

210.887

TOTAL BORROWING

240.038

282.683

242.917

DEFERRED TAX LIABILITIES

54.983

42.742

36.169

 

 

 

 

TOTAL

717.899

592.511

481.082

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

528.578

416.288

403.455

Capital work-in-progress

79.864

28.669

0.196

 

 

 

 

INVESTMENT

1.231

1.231

1.231

DEFERREX TAX ASSETS

0.259

0.344

0.569

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

76.973
44.830

20.035

 

Sundry Debtors

72.642
76.190

30.954

 

Cash & Bank Balances

7.808
8.755

12.408

 

Other Current Assets

0.000
0.000

0.000

 

Loans & Advances

241.881
173.521

126.936

Total Current Assets

399.304
303.296

190.333

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

123.225
73.052

55.608

 

Other Current Liabilities

25.187
2.243

2.748

 

Provisions

142.925
82.022

56.346

Total Current Liabilities

291.337
157.317

114.702

Net Current Assets

107.967
145.979

75.631

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

717.899

592.511

481.082

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

732.196

440.900

NA

 

 

Other Income

 

 

 

 

 

TOTAL                                    

732.196

440.900

NA

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

499.818

320.611

NA

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                    

499.818

320.611

NA

 

 

 

 

 

 

PROFIT/LOSS BEFORE TAX, DEPRECIATION AND AMORTISATION

(Including Depreciation)

120.289

39.601

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

 

21.473

19.678

 

 

 

 

 

 

PROFIT/LOSS BEFORE TAX

232.378

98.816

19.923

 

 

 

 

 

Less

TAX                                                                 

74.277

31.103

10.100

 

 

 

 

 

 

PROFIT/LOSS AFTER TAX

158.101

67.713

9.823

 

 

 

 

 

Add

GRATUITY ADJUSTMENT OF EARLIER YEARS  

0.306

0.000

0.000

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

213.139

151.435

143.367

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Final equity Dividend (Proposed)

2.250

2.250

1.500

 

 

Dividend Distribution Tax

0.368

0.374

0.255

 

 

Transfer to General Reserve

7.920

3.385

0.000

 

BALANCE CARRIED TO THE B/S

361.008

213.139

151.435

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Stability Testing and Development Charges

53.721

23.049

3.779

 

 

Exports

221.555

65.610

0.000

 

TOTAL EARNINGS

275.276

88.659

3.779

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

76.549

57.289

23.428

 

 

Capital Goods

92.686

36.294

6.697

 

TOTAL IMPORTS

169.235

93.583

30.125

 

 

 

 

 

 

Earnings Per Share (Rs.)

105.40

45.14

6.55

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

21.59
15.36

NA

 

 

 
 

 

Return on Total Assets

(PBT/Total Assets}

(%)

25.04
13.73

3.36

 

 

 
 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.55
0.37

0.10

 

 

 
 

 

Debt Equity Ratio

(Total Liability/Networth)

 

1.26
1.65

1.77

 

 

 
 

 

Current Ratio

(Current Asset/Current Liability)

 

1.37
1.93

1.66

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

Yes

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

No

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

BACKGROUND

 

Subject is a Company registered under the Companies Act, 1956. It was incorporated on 7th September, 1995. The Company is engaged in the business of Manufacturing of dermatological, pharmaceutical and therapeutic preparations, patent medicines, drugs, etc.  

 

 

Bankers Charges Report as per Registry

 

Corporate identity number (CIN) or foreign company

registration number of the company

U24230MH1995PTC092485

Name of the company

ENCUBE ETHICALS PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

Unit No. 24, Steelmada Industrial Estate, Marol  Village, Andheri (East), Mumbai – 400 059, Maharashtra, India

E-mail: kirit.v@encubeethicals.com

This form is for

Modification of charge

Charge identification (ID) number of the charge to be modified

10171735

Type of charge

·         Book debts

·         Movable property (not being pledge)

·         Floating charge

Particular of charge holder

HDFC Bank Limited, HDFC Bank House, Senapati Bapat Marg, Lower Parel West, Mumbai – 400 013, Maharashtra, India

E-mail: RBBform8@hdfcbank.com

Nature of instrument creating charge

Supplementary Letter of Hypothecation.

Date of instrument Creating the charge

14.12.2012

Amount secured by the charge

Rs.110.000 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest

Interest at the rate as may be communicated by the Bank from time to time.

 

Terms of Repayment

On demand.

 

Margin

As may be stipulated by the Bank from time to time.

 

Extent and Operation of the charge

Hypothecation by way of First Charge on Company's Stocks, Book Debts to secure as a continuing security as mentioned in Column No.15 below for the repayment of Rs.110.000 Millions together with interest, costs, charges, expenses and other moneys due and payable by the Company to the Bank.

 

Others

NIL

Short particulars of the property or asset(s) charged (including complete address and location of the property)

Stock-in-trade, consisting of raw materials, goods in process of manufacturing finished goods, and other merchandise whatsoever being movable properties, now

 

All the debts, that is, all the book debts, outstandings, monies receivables, claims,  bills, invoice documents, contracts, guarantees, and rights which are now

Date of instrument modifying the charge

01.11.2012

Particulars of the present modification

The Charge shall now stand increased from Rs.80.000 Millions to Rs.110.000 Millions against the security of Stocks, Book Debts of the Company.

 

 

FIXED ASSETS

 

·         Leasehold Land at Goa

·         Staff Quarters at Goa

·         Brands

·         Ceptidar

·         Trade Mark

·         Factory Building

·         Office Building

·         Plant and Machinery

·         Electrical Installations and Fittings

·         Spares and Tools

·         Ventilation and A.C. Systems

·         Office Equipments

·         Computer and Software

·         Other Factory Equipments

·         Furniture and Fixtures

·         Vehicles

·         R and D Center

·         R and D Equipment

·         R and D Electrical Installation

·         R and D Center Computers

·         R and D Ventilation and AC System

·         R and D Furniture and Fixtures

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.85

UK Pound

1

Rs.88.16

Euro

1

Rs.71.54

 

 

INFORMATION DETAILS

 

Report Prepared by :

VRN

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.